Julia Senkiv
Impact in
-
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Synthesis of heterocyclic compounds
- Synthesis and Biological Evaluation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Synthesis and biological activity 7
- Synthesis and Characterization of Heterocyclic Compounds 5
- Synthesis of heterocyclic compounds 3
-
- Fibroblast Growth Factor Research 4
- Co-authors
- Rostyslav Stoika (8 shared papers)Roman Lesyk (8 shared papers)Walter Berger (7 shared papers)Andrzej Gzella (6 shared papers)Christian R. Kowol (6 shared papers)Petra Heffeter (7 shared papers)Nataliya Finiuk (5 shared papers)Bernhard Englinger (4 shared papers)
In The Last Decade
Julia Senkiv
15 papers receiving 290 citations
Peers
Comparison fields: 5 of 53
- Organic Chemistry 137
- Biomaterials 33
- Oncology 51
- Biochemistry 14
- Toxicology 6
Countries citing papers authored by Julia Senkiv
This map shows the geographic impact of Julia Senkiv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Senkiv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Senkiv more than expected).
Fields of papers citing papers by Julia Senkiv
This network shows the impact of papers produced by Julia Senkiv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Senkiv. The network helps show where Julia Senkiv may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Senkiv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2017 | 53 | |
| 3 | 2013 | 33 | |
| 4 | 2018 | 30 | |
| 5 | 2021 | 24 | |
| 6 | 2022 | 23 | |
| 7 | 2020 | 21 | |
| 8 | 2014 | 14 | |
| 9 | 2018 | 10 | |
| 10 | 2022 | 7 | |
| 11 | 2019 | 6 | |
| 12 | 2021 | 5 | |
| 13 | Conjugation of anticancer drugs with novel PEG-containing nanocarrier provides circumvention of drug-resistance mechanisms in vitro and protects of general toxicity in vivo | 2017 | 2 |
| 14 | 2016 | 1 | |
| 15 | 2025 | 1 |
About Julia Senkiv
Julia Senkiv is a scholar working on Organic Chemistry, Molecular Biology, Biomaterials, Biomedical Engineering and Toxicology, having authored 15 papers that have together received 296 indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), Fibroblast Growth Factor Research (4 papers), Synthesis of heterocyclic compounds (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Boron Compounds in Chemistry (2 papers). The work is most often cited by research in Organic Chemistry (137 citations), Biomaterials (33 citations), Oncology (51 citations), Biochemistry (14 citations) and Toxicology (6 citations). Julia Senkiv has collaborated with scholars based in Ukraine, Poland and Austria. Frequent co-authors include Rostyslav Stoika, Roman Lesyk, Walter Berger, Andrzej Gzella, Christian R. Kowol, Petra Heffeter, Nataliya Finiuk, Bernhard Englinger, Dmytro Havrylyuk and Iryna Kril. Their work appears in journals such as Molecules, Journal of Biomedical Nanotechnology, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.